top of page

J Pharm Sci

Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 2: Model for the Drug-combination Nanoparticles.

https://www.sciencedirect.com/science/article/pii/S0022354921005529?dgcid=coauthor

January 31th, 2022

J Pharm Sci

Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 1: Model for the Free-Drug Mixture

https://www.sciencedirect.com/science/article/abs/pii/S0022354921005475?dgcid=coauthor

December 9th, 2021

J Pharm Sci

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates

https://www.sciencedirect.com/science/article/pii/S0022354920307486

January 15th, 2021

Frontiers in Pharmacology
Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments
https://www.frontiersin.org/articles/10.3389/fphar.2020.603242/full

January 15th, 2021

Pharmaceutical Research
Novel Long-Acting Drug Combination Nanoparticles Composed of Gemcitabine and Paclitaxel Enhance Localization of Both Drugs in Metastatic Breast Cancer Nodules
https://link.springer.com/article/10.1007/s11095-020-02888-8
September 23th, 2020

J PharmSci
Integration of Computational and Experimental Approaches to Elucidate Mechanisms of First-Pass Lymphatic Drug Sequestration and Long-Acting Pharmacokinetics of the Injectable Triple-HIV Drug Combination TLC-ART 101

anuary 29th, 2020

bottom of page